Skip to content
Business Company News

Capricorn Metals awards MACA five-year extension at Karlawinda Gold Project and preferred status for Mt Gibson Gold Project

MACA 2 mins read

Mining services provider MACA, a Thiess company, has been awarded a five-year contract extension for works at Capricorn Metals Ltd’s Karlawinda Gold Project in the Pilbara region of Western Australia.


The contract, which includes a client option to extend beyond 2030, covers full mining services, including load and haul, drill and blast, engineering and technical services.


The Karlawinda Gold Mine, located 60km south-east of Newman in Western Australia, has a mine life of over 10 years and includes approximately 4000 square kilometres of tenure prospective for further gold discoveries.


In 2020, MACA was awarded a five-year contract for a scope of works that included greenfield development of the mine, non-process infrastructure and sealing of the airstrip, as well as labour and equipment in support of Capricorn’s construction of the mill.


The achievements to date and this contract extension are a testament to MACA’s trusted relationship with Capricorn, built through the close collaboration of the respective teams across a broad range of disciplines.


In addition to the Karlawinda extension and after a thorough process, MACA has also been selected as the preferred mining contractor for Capricorn’s Mt Gibson Gold Project in the Murchison region of WA.


Capricorn Executive Chairman Mark Clark said: “We are pleased to execute the contract extension for the expanded Karlawinda gold project, underscoring our long-standing partnership with MACA built on mutual trust and reliable execution.


“We thank MACA for their strong contribution to our business to date and look forward to working together successfully with them for many years to come.”


Thiess Group Executive – Australia West David Greig emphasised the importance of MACA’s partnership with Capricorn: “Both entities are a proud product of the West Australian mining industry and have a strong understanding of what it takes to assemble quality teams to deliver sustainable value through the cycles.

“Karlawinda and Mt Gibson highlight of the importance of the mining industry to regional employment, career development and positive community outcomes.  We are very proud to be a part of Capricorn’s development.”


Thiess Group Executive Chair and CEO Michael Wright said: “This contract will see MACA further embed their presence within the WA gold industry, which has world-class reserves and production, backed by a strong exploration pipeline.


“The award highlights the commitment by the Thiess Group to support its operating companies to service their respective clients long term, which is critical to our strategy to continue to diversify our commodity portfolio and geographic footprint.”


MACA joined the Thiess Group in 2022. Its service offering to the hard rock mining industry is complemented by the subsequent acquisitions of underground mining service provider PYBAR and engineering service provider Mintrex. MACA remains focused on delivering safe, efficient, and reliable services – harnessing the power of its people and technology to drive sustainable change.

 
<ENDS>

Captions for attached photo: 

  • MACA Karlawinda.jpg: The Karlawinda Gold Project covers approximately 4000 square kilometres of tenure prospective for further gold discoveries.

About us:

MACA is an Australian-founded contracting group servicing the resources and construction industries for more than 20 years. With a team of highly skilled and dedicated professionals, MACA delivers operational expertise and equipment tailored to suit the needs of clients and end-users.

MACA is a wholly owned subsidiary of Thiess Group Holdings Pty Ltd.


Contact details:

Kellie Bombardieri, Communication and Marketing Manager – 0458 871 569

Media

More from this category

  • Business Company News, Medical Health Aged Care
  • 08/07/2025
  • 11:08
Nova Eye Medical (ASX:EYE)

Nova Eye Medical Delivers Record Revenues for FY25

HIGHLIGHTS Record revenues of A$28.8m for the year ended 30 June 2025 and in line with guidance Six consecutive half-years of growth in the USA with H2FY25 US sales up 25% onpcp Q4FY25 sales of A$8.4m the highest on record Nova Eye Medical Limited (ASX: EYE) (Nova Eye or the Company) is pleased to report a record sales result for FY25. Group revenue for FY25 reached A$28.8 million (US$18.4 million), up 21% (in constant currency) from FY24. Key drivers include: US sales of US$14.2 million, up 25% withiTrack™ Advance delivering six consecutive half-years of revenue growth. H2FY25 sales A$15.7 million…

  • Business Company News, Manufacturing
  • 08/07/2025
  • 10:38
Jane Morgan Management

Amaero Unlocks Velo3D Supply Agreement with Powder Certification from Auburn’s NCAME

Sydney, Australia – Amaero Ltd (ASX:3DA, OTC: AMROF) (“Amaero” or “the Company”) has entered into a strategic collaboration with Auburn University’s National Center for Additive Manufacturing Excellence (NCAME) to accelerate development and testing of its proprietary C103 and Ti64 alloy powders. The collaboration has already delivered key milestones. NCAME has verified that Amaero’s powders meet key aerospace and additive manufacturing standards, including ASTM F3635 for C103 and AMS7015/ASTM F3001 for Ti64. As a result, Amaero has met the powder qualification condition set by advanced 3D printing company Velo3D - clearing the way for initial commercial orders. Velo3D has now placed…

  • Contains:
  • Biotechnology, Business Company News
  • 08/07/2025
  • 10:02
Jane Morgan Management

BlinkLab Expands U.S. Clinical Trial Network – University of Nebraska Medical Center Engaged as Second Site in Main Phase of FDA 510(k) Study

BlinkLab Limited (ASX:BB1) (“BlinkLab” or “the Company”) is pleased to announce the expansion of its U.S. clinical trial network with the University of Nebraska Medical Center (UNMC) engaged as the second site in the main phase of its FDA 510(k) study for BlinkLab Dx 1 – its smartphone-based diagnostic tool for early autism detection. Highlights Second U.S. Site: University of Nebraska Medical Center (UNMC) selected as second site for BlinkLab’s pivotal FDA 510(k) autism diagnostic trial. Pilot Phase Near Completion: BlinkLab’s 100-participant pilot study has been progressing towards completion, with results expected this quarter. Main Study Scaling: An additional 750–900…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.